[1]
S. Ananthan, “Artificial Intelligence in Pharmaceutical Regulatory Affairs and Medical Science Liaison Activities: A Comprehensive Review”, Int J Drug Reg Affairs, vol. 13, no. 4, pp. 52-56, Dec. 2025.